Amplifon (OTCMKTS:AMFPF) Stock Price Up 12.7% – Here’s What Happened

Shares of Amplifon S.p.A. (OTCMKTS:AMFPF) rose 12.7% on Monday . The stock traded as high as $16.49 and last traded at $16.49. Approximately 4,454 shares changed hands during mid-day trading, an increase of 1,899% from the average daily volume of 223 shares. The stock had previously closed at $14.63.

Analysts Set New Price Targets

Separately, BNP Paribas initiated coverage on shares of Amplifon in a research note on Monday, October 20th. They set an “outperform” rating on the stock. Two research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock presently has an average rating of “Buy”.

Amplifon Stock Performance

The company has a fifty day moving average price of $16.21 and a two-hundred day moving average price of $18.32. The firm has a market cap of $3.72 billion, a price-to-earnings ratio of 29.45 and a beta of 0.44. The company has a debt-to-equity ratio of 1.14, a current ratio of 0.62 and a quick ratio of 0.54.

Amplifon (OTCMKTS:AMFPF) last released its earnings results on Thursday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.10. Amplifon had a return on equity of 14.28% and a net margin of 4.74%.The firm had revenue of $661.00 million for the quarter, compared to analyst estimates of $673.24 million.

Amplifon Company Profile

Amplifon is a global leader in hearing care, specializing in the retail and distribution of hearing aids, accessories and related services. The company offers a full suite of solutions including diagnostic hearing assessments, personalized hearing aid fittings, follow-up care, tinnitus management and hearing protection. Through its network of branded stores and partner outlets, Amplifon serves individuals across the full spectrum of hearing needs, from prevention and early detection to long-term aftercare.

Founded in Milan in 1950 by Algernon Charles Holland, Amplifon has grown from a single audiology centre into a multinational organization.